Christopher Yea, Chief Development Officer: KalVista Pharmaceuticals KALV Sell · Filed 24/02/21

Trade details

Type: Insider sale
Amount: $170,067.83
Shares · price: 12,053 sh · $14.11 a share
Held after: 72,895 sh
Stock: KalVista Pharmaceuticals KALV
Person: Christopher YeaChief Development Officer
Trade date: 24/02/20
Filed: 24/02/21
Days to filing: 1 days

Sold 14.2% of holdings

Share of holding sold: 14.2%

KalVista Pharmaceuticals trades, last 26 weeks

What else happened in KalVista Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/01/21~24/03/21

Christopher Yea's recent trades

Christopher YeaChief Development Officer
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$905.2K
33,800 sh
$905.2K
Filed 05/29
Traded 05/27
Christopher YeaChief Development Officer
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$52.6K
1,966 sh
$52.6K
Filed 05/27
Traded 05/26
Christopher YeaChief Development Officer
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$63.1K
2,358 sh
$63.1K
Filed 05/26
Traded 05/22
Christopher YeaChief Development Officer
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$29.7K
1,108 sh
$29.7K
Filed 05/19
Traded 05/18
Christopher YeaChief Development Officer
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$67.7K
4,347 sh
$67.7K
Filed 02/24
Traded 02/23